Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 133

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 133
---
 a governmental authority; (2) keep the other parties to the Divestiture Agreement reasonably informed with respect to the status of any such submissions and filings to any governmental authority in connection with the Divestiture and any developments, meetings, or discussions with any governmental authority in respect thereof; and (3) not independently participate in any meeting, hearing, proceeding or discussions with or before any governmental authority in respect of the Divestiture without giving the other parties to the Divestiture Agreement reasonable prior notice of such meeting, hearing, proceeding or discussion, and, unless prohibited by such governmental authority, the opportunity to attend or participate. Regulatory Laws Aadi and Kaken have each agreed to use commercially reasonable efforts to avoid or eliminate legal impediments so as to enable the closing of the Divestiture to occur as expeditiously as possible. The Divestiture Agreement provides that no party to the Divestiture Agreement nor any of its respective affiliates is required to (1) initiate or otherwise participate in any legal proceeding with any governmental authority, (2) commit to or effect the sale, lease, license, divestiture or disposition of any assets, rights, product lines or businesses of such party or any of its respective affiliates, (3) terminate any existing relationships, contractual rights or obligations of such party or any of its respective affiliates, (4) terminate any joint venture or other arrangement, (5) create any relationship, contractual rights or obligations of such party or any of its respective affiliates, (6) effectuate any other change or restructuring of such party or any of its respective affiliates or (7) otherwise take or commit to take any actions, including agreeing to prior approval restrictions, with respect to the businesses, product lines or assets of such party or any of its respective affiliates, in each case that would be material to the FYARRO Business or the benefits Kaken would attain by the purchase thereof. Indemnification Subject to certain exceptions set forth in the Divestiture Agreement, all representations, warranties, covenants and other agreements contained in the Divestiture Agreement or any of the other transaction documents, or any schedule, exhibit or certificate delivered in connection with the Divestiture Agreement or any of the other transaction documents, will survive the completion of the Divestiture as follows:

| • |     | certain representations of Aadi will survive the completion of the Divestiture for 30 days following the 
 expiration of the applicable statute of limitations;                                                     |

| • |     | certain representations of Aadi and all